Results 201 to 209 of about 15,205 (209)

Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study. [PDF]

J Am Heart Assoc
Martínez-Falguera D, Aranyó J, Ferrer-Curriu G, Teis A, Revuelta-Lopez E, Diaz-Güemes I, Monguió-Tortajada M, Fadeuilhe E, Rodríguez-Leor O, Poblador F, Montejo B, Roura S, Villuendas R, Sarrias A, Bazan V, Jorge E, Delgado V, Jimenez-Trinidad FR, Rigol M, Martinez-Micaelo N, Amigó N, Bayes-Genis A, Bisbal F, Gálvez-Montón C.   +23 more
europepmc   +1 more source

Sacubitril/Valsartan-induced Angioedema. [PDF]

Intern Med
Hiraoka Y, Nagayama K.
europepmc   +1 more source

A randomized controlled trial comparing sacubitril/valsartan and telmisartan in patients with HFrEF: efficacy and safety evaluation

Kamlesh Guleria, Dinesh Kansal, Atal Sood, Mukul Kumar   +3 more
openalex   +2 more sources

Improvement in Right Ventricular Function and Pulmonary Pressures in Patients With Severe Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction Treated With Sacubitril-Valsartan. [PDF]

Pulm Circ
Abofrekha B, Jdaidani J, Shadi M, Sanayeh EB, Agarwal A, Zaidan N, Rojas-Marte GR.   +6 more
europepmc   +1 more source

Letter to the Editor in response to the article 'Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan'. [PDF]

J Diabetes Investig
Khalid D, Siddiqui MS.
europepmc   +1 more source

Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT Indication. [PDF]

J Clin Med
Szabó KM, Tóth A, Nagy L, Nagy LT, Sándorfi G, Clemens M, Nagy AC, Ráduly AP, Borbély A, Barta J, Csanádi Z.   +10 more
europepmc   +1 more source